According to HealthDay Reporter Steven Reinberg (lifeclinic.com)
the amino acid known as amino acid supplement L-arginine may not help older individuals after aheart attack after all.
Early research studies had suggested that L-arginine could potentially reduce blood vessel stiffness.
But the latest findings, which seems to run counter to that research, appears in the January fourth issue of the Journal of the American Medical Association and comes from a clinical trial that was ended early after 6 patients had died.
"L-arginine administration did not improve cardiac remodeling over a 6 month period," said Dr. Gary Gerstenblith, a professor of medicine at Johns Hopkins Medical School in Baltimore, Maryland.
In their research study, Gerstenblith and his colleagues randomly assigned one hundred and fisty three heart attack patients either three grams of L-arginine or a placebo daily for 6 months. At 6 months, the researchers found that L-arginine did not reduce vascular stiffness, improve ejection-fraction, or even help clinical outcomes.
On the contrary, they discovered an increased risk of death in older patients taking L-arginine compared with those taking a placebo. 6 patients in the L-arginine group died during the 6 month study period, while none in the placebo group had died. This led the researchers to end the trial early.
...............Well, just another instance where the medical and health establishment had it completely backwards. I see a pattern forming?
Time will tell I suppose.
the amino acid known as amino acid supplement L-arginine may not help older individuals after aheart attack after all.
Early research studies had suggested that L-arginine could potentially reduce blood vessel stiffness.
But the latest findings, which seems to run counter to that research, appears in the January fourth issue of the Journal of the American Medical Association and comes from a clinical trial that was ended early after 6 patients had died.
"L-arginine administration did not improve cardiac remodeling over a 6 month period," said Dr. Gary Gerstenblith, a professor of medicine at Johns Hopkins Medical School in Baltimore, Maryland.
In their research study, Gerstenblith and his colleagues randomly assigned one hundred and fisty three heart attack patients either three grams of L-arginine or a placebo daily for 6 months. At 6 months, the researchers found that L-arginine did not reduce vascular stiffness, improve ejection-fraction, or even help clinical outcomes.
On the contrary, they discovered an increased risk of death in older patients taking L-arginine compared with those taking a placebo. 6 patients in the L-arginine group died during the 6 month study period, while none in the placebo group had died. This led the researchers to end the trial early.
...............Well, just another instance where the medical and health establishment had it completely backwards. I see a pattern forming?
Time will tell I suppose.
0 Comments:
Post a Comment
<< Home